Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A OTT

Showing results (501-510 of 667) with videos related to

Pageof 67
Sort By:
Clinical Immunology (Orlando, Fla.)|May 5, 2005
Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controlsPatrick A Ott, Bernhard A Herzog, Stefan Quast, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 16, 2023
Parental Engagement in Consent Processes for Enrollment in Biomedical HIV Prevention Trials: Implications for Minor Adolescents' Willingness to ParticipateAmelia Knopf, Claire Burke Draucker, J Dennis Fortenberry, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrenceKonstanze Miehle, Andrea Tannapfel, Peter Lamesch, et al.
Journal of Immunological Methods|February 26, 2004
CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseasesPatrick A Ott, Beate R Berner, Bernhard A Herzog, et al.
Cellular Immunology|November 1, 2005
IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assaysStefan Quast, Wenji Zhang, Carey Shive, et al.
Plos One|March 16, 2026
A pilot randomized controlled trial to explore the feasibility of a peer-delivered single-session brief intervention for youth with moderate risk substance useFlorence Jaguga, Matthew Turissini, Edith Kamaru Kwobah, et al.
Cancer Chemotherapy and Pharmacology|October 16, 2012
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trialPatrick A Ott, Jason Chang, Kathleen Madden, et al.
ACS Nano|July 12, 2012
Epitaxial graphene nanoribbon array fabrication using BCP-assisted nanolithographyGuanxiong Liu, Yanqing Wu, Yu-Ming Lin, et al.
PLOS Global Public Health|October 24, 2024
A scoping review of substance use brief interventions in AfricaFlorence Jaguga, Sarah Kanana Kiburi, Eunice Temet, et al.
Oncoimmunology|October 10, 2015
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumabRavi A Chandra, Tyler J Wilhite, Tracy A Balboni, et al.
Pageof 67

Showing results (501-510 of 667) with videos related to

Sort By:
Pageof 67
Clinical Immunology (Orlando, Fla.)|May 5, 2005
Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controlsPatrick A Ott, Bernhard A Herzog, Stefan Quast, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 16, 2023
Parental Engagement in Consent Processes for Enrollment in Biomedical HIV Prevention Trials: Implications for Minor Adolescents' Willingness to ParticipateAmelia Knopf, Claire Burke Draucker, J Dennis Fortenberry, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrenceKonstanze Miehle, Andrea Tannapfel, Peter Lamesch, et al.
Journal of Immunological Methods|February 26, 2004
CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseasesPatrick A Ott, Beate R Berner, Bernhard A Herzog, et al.
Cellular Immunology|November 1, 2005
IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assaysStefan Quast, Wenji Zhang, Carey Shive, et al.
Plos One|March 16, 2026
A pilot randomized controlled trial to explore the feasibility of a peer-delivered single-session brief intervention for youth with moderate risk substance useFlorence Jaguga, Matthew Turissini, Edith Kamaru Kwobah, et al.
Cancer Chemotherapy and Pharmacology|October 16, 2012
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trialPatrick A Ott, Jason Chang, Kathleen Madden, et al.
ACS Nano|July 12, 2012
Epitaxial graphene nanoribbon array fabrication using BCP-assisted nanolithographyGuanxiong Liu, Yanqing Wu, Yu-Ming Lin, et al.
PLOS Global Public Health|October 24, 2024
A scoping review of substance use brief interventions in AfricaFlorence Jaguga, Sarah Kanana Kiburi, Eunice Temet, et al.
Oncoimmunology|October 10, 2015
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumabRavi A Chandra, Tyler J Wilhite, Tracy A Balboni, et al.
Pageof 67